Company Performance - QuidelOrtho reported quarterly earnings of 0.74pershare,exceedingtheZacksConsensusEstimateof0.58 per share, and up from 0.44pershareayearago,representinganearningssurpriseof27.59692.8 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 0.30%, although this is a decrease from year-ago revenues of 711million[2]−Overthelastfourquarters,QuidelOrthohasconsistentlysurpassedconsensusEPSestimatesandrevenueestimates[2]StockPerformance−QuidelOrthoshareshavedeclinedapproximately41.80.14 on revenues of 621.72million,andforthecurrentfiscalyear,itis2.31 on revenues of $2.7 billion [7] - The outlook for the Medical - Products industry, to which QuidelOrtho belongs, is currently in the bottom 28% of over 250 Zacks industries, which may impact the stock's performance [8]